← FDA Drug Approvals (Drugs@FDA)
ATORVASTATIN CALCIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2023-12-21
Drug application
- FDA Application #
ANDA217634- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ATORVASTATIN CALCIUM
- Generic name
- Atorvastatin Calcium
- Active ingredients
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- STRIDES PHARMA
- First approval
- 2023-12-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown